Uncategorized
Ocular Therapeutix reports third-quarter net loss of $7.3 million
Ocular Therapeutix reported a third-quarter net loss of approximately $7.3 million, or $0.48 per share, compared with a net loss of $3.5 million, or $1.34 per share, in the same quarter last year, according to a press release.Total operating expenses were $6.9 million, compared with $3.4 million a year ago.